(Q39470443)

English

Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells

scientific article published on 21 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

0 references

prostate carcinoma

1 reference

based on heuristic

inferred from title

Horng-Heng Juang

object named as

Horng-Heng Juang

6

0 references

author name string

Li-Chuan Chung

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ke-Hung Tsui

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tsui-Hsia Feng

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Shiow-Ling Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Phei-Lang Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

21 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1666-1676

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mechanisms of action of novel agents for prostate cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Potential protection of curcumin against hypoxia-induced decreases in beta-III tubulin content in rat prefrontal cortical neurons

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Cobalt chloride attenuates hypobaric hypoxia induced vascular leakage in rat brain: molecular mechanisms of action of cobalt chloride

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Prostate-specific antigen kinetics in localized and advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Usefulness of hypoxia inducible factor-1 alpha in evaluating the prostatic adenocarcinoma viability following neoadjuvant hormone therapy.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Hypoxia increases androgen receptor activity in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Therapeutic manipulation of the HIF hydroxylases

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

New mechanisms and therapeutic potential of curcumin for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Curry spice curcumin and prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Chemopreventive potential of curcumin in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Correlation between pretreatment serum biochemical markers and treatment outcome for prostatic cancer with bony metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Chronic hypoxia, physical exercise and PSA: correlation during high-altitude trekking (2004 K2 expedition)

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201100328

21 January 2018

Identifiers

10.1002/MNFR.201100328

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_shbepk2nqjdqvnnhod2mdyrd7y

1 reference

https://api.fatcat.wiki/v0/release/shbepk2nqjdqvnnhod2mdyrd7y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39470443&oldid=1842990382"